XML 22 R11.htm IDEA: XBRL DOCUMENT v3.19.1

Accrued Expenses

3 Months Ended

Mar. 31, 2019

Accrued Expenses

Accrued Expenses

5. Accrued Expenses

The following is a summary of the Company’s accrued expenses:

		March 31,			December 31,
		2019			2018
Accrued research and development expenses		$	3,967,216		$	3,483,741
Accrued consulting and other professional fees			457,877			140,397
Accrued employee benefits			440,136			385,789
Other accrued expenses			317,397			263,693
Accrued expenses		$	5,182,626		$	4,273,620

X

- Definition

The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a),20,24)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration